Dr. Rifat Parvez is a pharmacist who is specialized in Nutrition Support in Skillman, New Jersey. Patients can reach him at 35 Robin Drive, Skillman or contact him on 609-203-4135. Active license number of Dr. Rifat Parvez is 029953 for Nutrition Support in New York. Dr. Rifat Parvez is a licensed pharmacist who has demonstrated specialized knowledge and skill in maintenance and/or restoration of optimal nutritional status, designing and modifying treatment according to patient needs.
Complete Profile:
Dr. Rifat Parvez speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Rifat Parvez
Specialization:
Nutrition Support
Credentials:
PH.D.
Gender:
Male
Location:
35 Robin Drive, Skillman, New Jersey, 08558
Phone:
609-203-4135
Fax:
609-497-0746
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Rifat Parvez are as mentioned below.
NPI Number:
1366764417
NPI Enumeration Date:
17 Feb, 2010
NPI Last Update On:
17 Feb, 2010
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Rifat Parvez are as mentioned below.
Specialization
License Number
State
Status
Nutrition Support
029953
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
35 Robin Dr, Skillman, New Jersey
Zip:
08558-2012
Phone Number:
609-203-4135
Fax Number:
609-497-0746
Patients can reach Dr. Rifat Parvez at 35 Robin Drive, Skillman, New Jersey or can call on phone at 609-203-4135.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.